|
|
|
|
LEADER |
00000nam a22000005i 4500 |
001 |
978-3-211-73574-9 |
003 |
DE-He213 |
005 |
20220119125206.0 |
007 |
cr nn 008mamaa |
008 |
100301s2007 au | s |||| 0|eng d |
020 |
|
|
|a 9783211735749
|9 978-3-211-73574-9
|
024 |
7 |
|
|a 10.1007/978-3-211-73574-9
|2 doi
|
050 |
|
4 |
|a RC346-429.2
|
072 |
|
7 |
|a MJN
|2 bicssc
|
072 |
|
7 |
|a MED056000
|2 bisacsh
|
072 |
|
7 |
|a MKJ
|2 thema
|
082 |
0 |
4 |
|a 616.8
|2 23
|
245 |
1 |
0 |
|a Neuropsychiatric Disorders
|h [electronic resource] :
|b An Integrative Approach /
|c edited by Manfred Gerlach, Jürgen Deckert, Kay Double, Eleni Koutsilieri.
|
250 |
|
|
|a 1st ed. 2007.
|
264 |
|
1 |
|a Vienna :
|b Springer Vienna :
|b Imprint: Springer,
|c 2007.
|
300 |
|
|
|a IX, 341 p.
|b online resource.
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
347 |
|
|
|a text file
|b PDF
|2 rda
|
490 |
1 |
|
|a Journal of Neural Transmission. Supplementa
|
505 |
0 |
|
|a The meeting of minds and times with Peter Riederer: an appreciation -- Succi nervorum: a brief history of neurochemistry -- Neuronal differentiation and long-term culture of the human neuroblastoma line SH-SY5Y -- Endogenous oxidized indoles share inhibitory potency against [3H]isatin binding in rat brain -- Lipid content determines aggregation of neuromelanin granules in vitro -- Hydrogen peroxide is a true first messenger -- The therapeutic potential of siRNA in gene therapy of neurodegenerative disorders -- Tyrosinase is not detected in human catecholaminergic neurons by immunohistochemistry and Western blot analysis -- Luteolin protects rat PC 12 and C6 cells against MPP+ induced toxicity via an ERK dependent Keapl-Nrf2-ARE pathway -- Behavioural and expressional phenotyping of nitric oxide synthase-I knockdown animals -- Animal models in neurodegenerative diseases -- Morphological substrates of parkinsonism with and without dementia: a retrospective clinico-pathological study -- Ginsenoside Rd attenuates neuroinflammation of dopaminergic cells in culture -- Biochemistry of postmortem brains in Parkinson's disease: historical overview and future prospects -- Neuroprotection by propargylamines in Parkinson's disease: intracellular mechanism underlying the anti-apoptotic function and search for clinical markers -- Intrastriatal transplantation of mouse bone marrow-derived stem cells improves motor behavior in a mouse model of Parkinson's disease -- Low dose methylphenidate improves freezing in advanced Parkinson's disease during off-state -- The long-term effects of the neurotoxin l-trichloromethyl-1,2,3,4-tetrahydro-?-carboline (TaClo) on cognitive performance in rats -- Observations on the cortical silent period in Parkinson's disease -- CYP 2E1 mutant mice are resistant to DDC-induced enhancement of MPTP toxicity -- Pharmacokinetic studies of (-)-deprenyl and some of its metabolites in mouse -- Serum lipoprotein profile and APOE genotype in Alzheimer's disease -- VITA study: white matter hyperintensities of vascular and degenerative origin in the elderly -- ?-Lipoic acid as a new treatment option for Alzheimer's disease - a 48 months follow-up analysis -- Long-term abnormalities in brain glucose/energy metabolism after inhibition of the neuronal insulin receptor: implication of tau-protein -- Long-term tetrahydroaminoacridine treatment and quantitative EEG in Alzheimer's disease -- Enhanced apoptosis, oxidative stress and mitochondrial dysfunction in lymphocytes as potential biomarkers for Alzheimer's disease -- Central insulin resistance as a trigger for sporadic Alzheimer-like pathology: an experimental approach -- Brain antioxidant capacity in rat models of betacytotoxic-induced experimental sporadic Alzheimer's disease and diabetes mellitus -- Improving linear modeling of cognitive decline in patients with mild cognitive impairment: comparison of two methods -- Interaction of attention and graphomotor functions in children with attention deficit hyperactivity disorder -- Therapeutic drug monitoring of antidepressants - clinical aspects -- The immunological basis of glutamatergic disturbance in schizophrenia: towards an integrated view -- Deficits of neuronal glutamatergic markers in the caudate nucleus in schizophrenia -- Therapeutic drug monitoring of tricyclic antidepressants in everyday clinical practice -- FZD3 is not a risk gene for schizophrenia: a case-control study in a Caucasian sample -- Impaired cortical inhibition in adult ADHD patients: a study with transcranial magnetic stimulation* -- Association of Parkinson's disease with symptoms of attention deficit hyperactivity disorder in childhood -- Biostatistical analysis of gene microarrays reveals diverse expression clusters between macaque subspecies in brain SIV infection -- Kynurenines, redox disturbances and neurodegeneration in multiple sclerosis -- Neural stem cell transplantation in a model of fetal alcohol effects.
|
650 |
|
0 |
|a Neurology .
|
650 |
|
0 |
|a Clinical psychology.
|
650 |
1 |
4 |
|a Neurology.
|
650 |
2 |
4 |
|a Clinical Psychology.
|
700 |
1 |
|
|a Gerlach, Manfred.
|e editor.
|4 edt
|4 http://id.loc.gov/vocabulary/relators/edt
|
700 |
1 |
|
|a Deckert, Jürgen.
|e editor.
|4 edt
|4 http://id.loc.gov/vocabulary/relators/edt
|
700 |
1 |
|
|a Double, Kay.
|e editor.
|4 edt
|4 http://id.loc.gov/vocabulary/relators/edt
|
700 |
1 |
|
|a Koutsilieri, Eleni.
|e editor.
|4 edt
|4 http://id.loc.gov/vocabulary/relators/edt
|
710 |
2 |
|
|a SpringerLink (Online service)
|
773 |
0 |
|
|t Springer Nature eBook
|
776 |
0 |
8 |
|i Printed edition:
|z 9783211100769
|
776 |
0 |
8 |
|i Printed edition:
|z 9783211999066
|
776 |
0 |
8 |
|i Printed edition:
|z 9783211735732
|
830 |
|
0 |
|a Journal of Neural Transmission. Supplementa
|
856 |
4 |
0 |
|u https://doi.uam.elogim.com/10.1007/978-3-211-73574-9
|z Texto Completo
|
912 |
|
|
|a ZDB-2-SME
|
912 |
|
|
|a ZDB-2-SXM
|
950 |
|
|
|a Medicine (SpringerNature-11650)
|
950 |
|
|
|a Medicine (R0) (SpringerNature-43714)
|